Neurocognitive Alterations in Hypertensive Children and Adolescents

Journal of Clinical Hypertension

Volumn 14, Issue 6, 2012, Pages 353-359

  Lande, Marc B ^a   Kupferman, Juan C ^b   Adams, Heather R ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; ENALAPRIL; METHYLDOPA; METOPROLOL; THIAZIDE DIURETIC AGENT; VERAPAMIL;

ANTIHYPERTENSIVE THERAPY; ANXIETY; BEHAVIOR DISORDER; BRAIN BLOOD VESSEL; CEREBROVASCULAR REACTIVITY; CHILDHOOD DISEASE; CHRONIC KIDNEY DISEASE; COGNITIVE DEFECT; DATA BASE; DEPRESSION; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; LEARNING DISORDER; NEUROLOGIC EXAMINATION; OBESITY; PREVALENCE; PRIORITY JOURNAL; REVIEW;

ADOLESCENT; AGE FACTORS; ANTIHYPERTENSIVE AGENTS; CHILD; COGNITION DISORDERS; HUMANS; HYPERTENSION; NERVOUS SYSTEM DISEASES; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; RISK FACTORS; UNITED STATES;

EID: 84861872150     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2012.00661.x     Document Type: Review

References (50)

1. Launer LJ, Ross GW, Petrovitch H, et al. Midlife blood pressure and dementia: The Honolulu-Asia aging study. Neurobiol Aging. 2000;21:49-55.
2. Waldstein SR. Hypertension and neuropsychological function: a lifespan perspective. Exp Aging Res. 1995;21:321-352.
3. Waldstein SR, Snow J, Muldoon MF, Katzel LI. Neuropsychological consequences of cardiovascular disease. In: Tarter RE, Butters M, Beers SR, eds. Medical Neuropsychology. 2nd edn. New York, NY: Kluwer Academic/Plenum Publishers; 2001:51-83.
4. Waldstein SR, Manuck SB, Ryan CM, Muldoon MF. Neuropsychological correlates of hypertension: review and methodologic considerations. Psychol Bull. 1991;110:451-468.
5. Knecht S, Wersching H, Lohmann H, et al. High-normal blood pressure is associated with poor cognitive performance. Hypertension. 2008;51:663-668.
6. Shehab A, Abdulle A. Cognitive and autonomic dysfunction measures in normal controls, white coat and borderline hypertension. BMC Cardiovascular Disorders. 2011;11:3.
7. Waldstein SR, Jennings JR, Ryan CM, et al. Hypertension and neuropsychological performance in men: interactive effects of age. Health Psychol. 1996;15:102-109.
8. Suhr JA, Stewart JC, France CR. The relationship between blood pressure and cognitive performance in the third national health and nutrition examination survey (NHANES III). Psychosom Med. 2004;66:291-297.
9. Straus E, Sherman EMS, Spreen O. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. 3rd edn. New York, NY: Oxford University Press; 2006.
10. Pennington BF, Ozonoff S. Executive functions and developmental psychopathology. J Child Psychol Psychiatry. 1996;37:51-87.
11. Vicario A, Martinez CD, Baretto D, et al. Hypertension and cognitive decline: impact on executive function. J Clin Hypertens. 2005;7:598-604.
12. Waldstein SR, Katzel LI. Interactive relations of central versus total obesity and blood pressure to cognitive function. Int J Obes (Lond). 2006;30:201-207.
13. Gupta R, Solanki RK, Pathak V. Blood pressure is associated with cognitive impairment in young hypertensives. World J Biol Psychiatry. 2008;9:43-50.
14. Thyrum ET, Blumenthal JA, Madden DJ, Siegel W. Family history of hypertension influences neurobehavioral function in hypertensive patients. Psychosom Med. 1995;57:496-500.
15. Pierce TW, Elias MF. Cognitive function and cardiovascular responsivity in subjects with a parental history of hypertension. J Behav Med. 1993;16:277-294.
16. Waldstein SR, Ryan CM, Polefrone JM, Manuck SB. Neuropsychological performance of young men who vary in familial risk for hypertension. Psychosom Med. 1994;56:449-456.
17. Lande MB, Kaczorowski JM, Auinger P, et al. Elevated blood pressure and decreased cognitive function among school-age children and adolescents in the United States. J Pediatr. 2003;143:720-724.
18. Lande MB, Adams H, Falkner B, et al. Parental assessments of internalizing and externalizing behavior and executive function in children with primary hypertension. J Pediatr. 2009;154:207-212.
19. Gioia GA, Isquith PK, Guy SC, Kenworthy L. Behavior Rating Inventory of Executive Function. Lutz, FL: Pyschological Assessments Resources; 2000.
20. Achenbach TM, Rescorla LA. Manual of the ASEBA School-Aged Forms and Profiles. Burlington, VT: Research Center for Children, Youth, and Families; 2001.
21. Adams HR, Szilagyi PG, Gebhardt L, Lande MB. Learning and attention problems among children with pediatric primary hypertension. Pediatrics. 2010;126:e1425-9.
22. Samuels JA, Franco K, Wan F, Sorof JM. Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial. Pediatric Nephrology. 2006;21:92-95.
23. Mayes SD, Calhoun SL, Crowell EW. Learning disabilities and ADHD: overlapping spectrumn disorders. J Learn Disabil. 2000;33:417-424.
24. Ditto B, Seguin JR, Tremblay RE. Neuropsychological characteristics of adolescent boys differing in risk for high blood pressure. Ann Behav Med. 2006;31:231-232.
25. Sorof JM, Poffenbarger T, Franco K, et al. Isolated systolic hypertension, obesity, and hyperkinetic hemodynamic states in children. J Pediatr. 2002;140:660-666.
26. Flynn JT, Mitsnefes M, Pierce C, et al. Blood pressure in children with chronic kidney disease: a report from the chronic kidney disease in children study. Hypertension. 2008;52:631-637.
27. Lande MB, Gerson AC, Hooper SR, et al. Casual blood pressure and neurocognitive function in children with chronic kidney disease: a report of the children with chronic kidney disease cohort study. Cli J Am Soc Nephrol: CJASN. 2011;6:1831-1837.
28. Muldoon MF, Waldstein SR, Jennings JR. Neuropsychological consequences of antihypertensive medication use. Exp Aging Res. 1995;21:353-368.
29. Muldoon MF, Manuck SB, Shapiro AP, Waldstein SR. Neurobehavioral effects of antihypertensive medications. J Hypertens. 1991;9:549-559.
30. Miller RE, Shapiro AP, King HE, et al. Effect of antihypertensive treatment on the behavioral consequences of elevated blood pressure. Hypertension. 1984;1:202-208.
31. Muldoon MF, Waldstein SR, Ryan CM, et al. Effects of six anti-hypertensive medications on cognitive performance. J Hypertens. 2002;20:1643-1652.
32. Lande MB, Adams H, Falkner B, et al. Parental assessment of executive function and internalizing and externalizing behavior in primary hypertension after anti-hypertensive therapy. J Pediatr. 2010;157:114-119.
33. Sorof JM, Cardwell G, Franco K, Portman RJ. Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension. 2002;39:903-908.
34. Beebe DW, Ris MD, Kramer ME, et al. The association between sleep disordered breathing, academic grades, and cognitive and behavioral functioning among overweight subjects during middle to late childhood. Sleep. 2010;33:1447-1456.
35. Jonas BS, Lando JF. Negative affect as a prospective risk factor for hypertension. Psychosom Med. 2000;62:188-196.
36. Waldstein SR, Katzel LI. Stress-induced blood pressure reactivity and cognitive function. Neurology. 2005;64:1746-1749.
37. von Bohlen und Halbach O, Albrecht D. The CNS renin-angiotensin system. Cell Tissue Res. 2006;326:599-616.
38. Sink KM, Leng X, Williamson J, et al. Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the cardiovascular health study. Arch Intern Med. 2009;169:1195-1202.
39. Jennings JR. Autoregulation of blood pressure and thought: preliminary results of an application of brain imaging to psychosomatic medicine. Psychosom Med. 2003;65:384-395.
40. Jennings JR, Zanstra Y. Is the brain the essential in hypertension? Neuroimage. 2009;47:914-921.
41. Maeda H, Matsumoto M, Handa N, et al. Reactivity of cerebral blood flow to carbon dioxide in hypertensive patients: evaluation by the transcranial doppler method. J Hypertens. 1994;12:191-197.
42. Bright MG, Bulte DP, Jezzard P, Duyn JH. Characterization of regional heterogeneity in cerebrovascular reactivity dynamics using novel hypocapnia task and BOLD fMRI. Neuroimage. 2009;48:166-175.
43. Settakis G, Pall D, Molnar C, et al. Cerebrovascular reactivity in hypertensive and healthy adolescents: TCD with vasodilatory challenge. J Neuroimaging. 2003;13:106-112.
44. Settakis G, Pall D, Molnar C, et al. Hyperventilation-induced cerebrovascular reactivity among hypertensive and healthy adolescents. Kidney Blood Press Res. 2006;29:306-311.
45. Pall D, Lengyel S, Komonyi E, et al. Impaired cerebral vasoreactivity in white coat hypertensive adolescents. Eur J Neurol. 2011;18:584-589.
46. Wong LJ, Kupferman JC, Prohovnik I, et al. Hypertension impairs vascular reactivity in the pediatric brain. Stroke. 2011;42:1834-1838.
47. Kral MC, Brown RT, Nietert PJ, et al. Transcranial Doppler ultrasonography and neurocognitive functioning in children with sickle cell disease. Pediatrics. 2003;112:324-331.
48. Hill CM, Hogan AM, Onugha N, et al. Increased cerebral blood flow velocity in children with mild sleep-disordered breathing: a possible association with abnormal neuropsychological function. Pediatrics. 2006;118:e1100-8.
49. De Luca CR, Wood SJ, Anderson V, et al. Normative data from the CANTAB. I: development of executive function over the lifespan. J Clin Exp Neuropsychol. 2003;25:242-254.
50. Giedd JN. The teen brain: insights from neuroimaging. J Adolesc Health. 2008;42:335-343.